Tirbanibulin OverviewTirbanibulin, sold under the brand name Klisyri, is a medication for the treatment of actinic keratosis on the face or scalp. The most common side effects include local skin reactions, application site pruritus, and application site pain. Tirbanibulin was approved for medical use in the United States in December 2020. The U.S. Food and Drug Administration (FDA) ...
Read more Tirbanibulin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tirbanibulin
Recent Tirbanibulin Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Ointment: 1%
Other drugs which contain Tirbanibulin or a similar ingredient: (1 result)
- KLISYRI Tirbanibulin